What is Melodiol Global Health Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Melodiol Global Health's Average Total Inventories for the quarter that ended in Dec. 2023 was $1.24 Mil. Melodiol Global Health's Revenue for the
six
months ended in Dec. 2023 was $7.98 Mil.
Melodiol Global Health's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.16.
Melodiol Global Health's Inventory-to-Revenue for the quarter that ended in Dec. 2023
declined
from Jun. 2023 (0.58) to Jun. 2023 (0.16)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Melodiol Global Health's Days Inventory for the
six
months ended in Dec. 2023 was 39.24.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Melodiol Global Health's Inventory Turnover for the quarter that ended in Dec. 2023 was 4.65.
Melodiol Global Health Inventory-to-Revenue Historical Data
The historical data trend for Melodiol Global Health's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Melodiol Global Health's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Melodiol Global Health's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Melodiol Global Health's Inventory-to-Revenue falls into.
Melodiol Global Health Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Melodiol Global Health's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Melodiol Global Health (OTCPK:COPHD) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Melodiol Global Health's Days Inventory for the
six
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Melodiol Global Health Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Melodiol Global Health's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Melodiol Global Health (Melodiol Global Health) Business Description
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.
Melodiol Global Health (Melodiol Global Health) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COPHD has been successfully added to your 